Healthcare & Medical Devices Global On demand · 24-48h

Global High-Throughput Pipetting System Market Strategic Research Report

Global High-Throughput Pipetting System Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global High-Throughput Pipetting System Market
$1.01B2025
6.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Manual, Automatic

By Application: Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BICO, Revvity, Beckman Coulter, Hamilton, Formulatrix, SPT Labtech, Analytik Jena (Endress+Hauser), Agilent Technologies, Aurora Biomed, Mettler Toledo, Tecan, Eppendorf, Accuris Instruments, Gilson, Hudson Robotics, NAYO Biotechnology (Shanghai), Shanghai I-omics Biotech, Ashmar Scientific (Shanghai), Nanjing Vazyme Biotech, Beijing AMTK Technology Development, Shenzhen MGI Tech, Tiangen Biotech (Beijing) Co., Ltd., Suzhou PRCXI Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 151 pages
Market size 2025
$1.01B
Billion USD
Forecast CAGR
6.5%
2025-2032
Forecast 2032
$1.6B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global High-Throughput Pipetting System market size is predicted to grow from US$ 1,006 million in 2025 to US$ 1,554 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

In 2025, global High-Throughput Pipetting System production reached approximately 16.7 k units with an average global market price of around k US$100 per unit. Single-line annual production capacity averages 890 units with a gross margin of approximately 36%. The upstream of the High-Throughput Pipetting System industry includes precision machinery, electronic components, and software platforms, which are primarily concentrated in the field of new drug development. In the downstream applications, biopharmaceutical companies account for the highest share, approximately 40%, followed by government institutions, medical institutions, universities, and research institutions, each accounting for about 20%, with other application areas making up approximately 20%. The demand for High-Throughput Pipetting Systems in the biopharmaceutical industry is continuously growing, driven by the acceleration of new drug research and development and the increasing demand for automation. With the ever-increasing requirements for automation and precision in scientific research and clinical experiments, the market potential of High-Throughput Pipetting Systems is significant, particularly in the fields of personalized medicine and precision medicine.

The High-Throughput Pipetting System is a sophisticated instrument designed to automate the precise and efficient transfer of liquids in large volumes. By integrating advanced technologies such as robotic arms, microfluidic control, and programmable software, this system achieves unparalleled precision and speed in liquid handling tasks. The system's core functionality lies in its ability to perform multiple pipetting operations simultaneously, significantly reducing the time and labor required for sample preparation and analysis. This not only enhances the overall throughput of experiments but also minimizes the potential for human error, ensuring the reliability and reproducibility of results. The system's modular design allows for seamless integration with various labware and instruments, providing a versatile solution for a wide range of research applications.

Looking ahead, the High-Throughput Pipetting System industry is poised for advancements in automation and intelligence, moving towards miniaturization and portability, and supporting multi-channel operations and versatile designs to cater to the diverse needs of laboratories and clinical settings. The systems will be increasingly integrated and compatible, seamlessly connecting with Laboratory Information Management Systems (LIMS) while maintaining high precision and low error rates in operation. Furthermore, the focus on adaptive customization and cost-effectiveness will be crucial. Environmental sustainability and eco-friendliness will also be a priority. With the rise of personalized and precision medicine, the High-Throughput Pipetting System will play a pivotal role in fields such as gene editing and cell culture. Additionally, as global scientific research activities expand, the industry is expected to see new growth opportunities, particularly in emerging and developing markets worldwide.

Key Questions Addressed in this Report

What is the 10-year outlook for the global High-Throughput Pipetting System market?

What factors are driving High-Throughput Pipetting System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do High-Throughput Pipetting System market opportunities vary by end market size?

How does High-Throughput Pipetting System break out by Type, by Application?

This report presents a comprehensive overview of the global High-Throughput Pipetting System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Manual
  • Automatic

Segment by Accuracy

  • Milliliter(mL)
  • Microliter(μL)
  • Nanoliter(nL)
  • Picoliter(pL)

Segment by Form

  • Benchtop Type
  • Floor-standing Type

Segment by Application

  • Biopharmaceutical Company
  • Government Agency
  • Medical Institution
  • University and Research Institute
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global High-Throughput Pipetting System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biopharmaceutical Company, Government Agency, Medical Institution evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global High-Throughput Pipetting System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.01B
2025
Forecast
$1.6B
2032
CAGR
6.5%
2025–2032
영역들
5
global
Key companies
BICORevvityBeckman CoulterHamiltonFormulatrixSPT LabtechAnalytik Jena (Endress+Hauser)Agilent Technologies
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
ManualAutomatic
By Application
Biopharmaceutical CompanyGovernment AgencyMedical InstitutionUniversity and Research InstituteOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Manual
  • 3.1.3 Automatic
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biopharmaceutical Company
  • 4.1.3 Government Agency
  • 4.1.4 Medical Institution
  • 4.1.5 University and Research Institute
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BICO
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Revvity
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Beckman Coulter
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hamilton
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Formulatrix
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 SPT Labtech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Analytik Jena (Endress+Hauser)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Agilent Technologies
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Aurora Biomed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Mettler Toledo
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Tecan
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Eppendorf
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Accuris Instruments
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Gilson
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hudson Robotics
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 NAYO Biotechnology (Shanghai)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shanghai I-omics Biotech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Ashmar Scientific (Shanghai)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Nanjing Vazyme Biotech
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Beijing AMTK Technology Development
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shenzhen MGI Tech
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Tiangen Biotech (Beijing) Co., Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Suzhou PRCXI Biotechnology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global High-Throughput Pipetting System market size?
The global High-Throughput Pipetting System market is estimated at US$ 1.01 billion in 2025 (base year) and is projected to reach US$ 1.55 billion by 2032.
What growth rate is expected for the High-Throughput Pipetting System market through 2032?
The market is expected to grow at a CAGR of 6.5% from 2026 to 2032, expanding from US$ 1.01 billion in 2025 to US$ 1.55 billion in 2032, roughly 1.5 times its base-year value.
How is High-Throughput Pipetting System defined?
In 2025, global High-Throughput Pipetting System production reached approximately 16.7 k units with an average global market price of around k US$100 per unit. Single-line annual production capacity averages 890 units with a gross margin of approximately 36%. The upstream of the High-Throughput Pipetting System industry includes precision machinery, electronic components, and software platforms, which are primarily concentrated in the field of new drug development.
How is the High-Throughput Pipetting System market segmented by type?
By type, the market is segmented into Manual and Automatic.
What are the key applications of High-Throughput Pipetting System?
Key applications covered include Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute and Others.
Which companies are profiled in the High-Throughput Pipetting System market report?
Key players profiled include BICO, Revvity, Beckman Coulter, Hamilton, Formulatrix, SPT Labtech, Analytik Jena (Endress+Hauser) and Agilent Technologies, among 23 companies covered in total.
What geographies does the High-Throughput Pipetting System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for High-Throughput Pipetting System?
What factors are driving High-Throughput Pipetting System market growth, globally and by region?
Who should buy the High-Throughput Pipetting System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biopharmaceutical Company, Government Agency and Medical Institution, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the High-Throughput Pipetting System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.